CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Ross Milner MD FACS's blog
Bare-Metal or Covered SFA Stents: Still a struggle!
Smoking cessation and exercise regimens are the textbook answer to the treatment of patients with claudication symptoms. Surgical bypass can be complicated by wound-healing issues, graft thrombosis, etc. In light of this, the traditional approach to superficial femoral artery (SFA) disease is nonoperative, unless the patient has claudication that is debilitating and prevents the patient from performing their job appropriately.
Percutaneous therapy has changed our opinion of claudication. I (and many others) have become very aggressive about catheter-based approaches to SFA disease. My pref
EVAR Surveillance in 2010
I am returning now from the Society for Vascular Surgery (SVS) Meeting in Boston. I was honored to be asked to co-moderate one of the post-graduate courses offered by the SVS the day before the meeting. Ten endovascular experts, with a special interest in EVAR, spoke about surveillance, endoleaks and late failure management.
One point is very clear to me: we have made a tremendous amount of progress since Dr. Parodi’s initial EVAR report in 1990, but on the other hand, we still have not even come close to reaching a consensus about EVAR follow-up. CTA? Ultrasound? Pressure sensors? Tre
CREST: MI or Stroke? (In other words, Has CREST changed your practice?)
The CREST results were eagerly anticipated for many years. We hoped that a prospective, randomized trial for carotid disease would clarify how people should be treated with high-grade carotid stenosis. I don’t think that the actual picture is as clear as we were hoping when the trial results were announced.
I think it is clear that there is a slightly higher risk of MI for surgical patients. But, there is a slightly lower risk of neurologic events in the surgical arm. It also seems that older patients (greater than 70 years old) do better with an operation.
So, have you changed you
Reversal of End-Stage Renal Disease: One Aspect of Renal PTA
Renal angioplasty and stenting has lost some of its luster with the recent data presented. I would like to argue that there is still a value in treating some patients with renal artery occlusive disease. The idea for this blog came from a recent discussion with one of my old patients from Atlanta.
I previously partnered very closely with the transplant surgeons at Emory. We evaluated many patients with aorto-iliac occlusive disease prior to clearing them to be listed for renal transplantation. We would decide together if an intervention was warranted to assist with a successful renal transp
Collaboration: A Good Thing!
Vascular surgeons have developed clinical and technical skills that allow us to care for many of our patients on our own. In light of this, I think many of us have forgotten that there is a benefit to our patients to have more than one opinion regarding their most optimal care. As mentioned in my last blog, I recently moved to a new medical center. One of the biggest transitions in my professional life is a setting in which I work side by side in the Heart and Vascular Center with other specialists, including neurologists and cardiologists.
I have taken care of several patients in a short p
Embracing New Technology — Cautiously
As a vascular surgeon, I am constantly evaluating advances that help us care for our patients. I think this is especially true with the rapidly changing medical device technologies. I think we generally fall into three categories when considering new techniques: “the immediate-users, the wait-and-seers, and the complete naysayers.”
I have usually taken the “wait-and-see” approach. This is especially true for EVAR performed in a percutaneous manner. I have spoken to colleagues, heard about the training courses, and have seen some data in the literature. I have always said th
Vascular Disease Blogs
Frank J. Criado, MD, FACS, FSVM
Robert S. Dieter, MD, RVT and Aravinda Nanjundappa, MD, RVT
VDM Monthly Poll
Digital Supplements
Terumo Clinical Case Update This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
- Wednesday, September 8, 2010 - 17:17
- Wednesday, September 8, 2010 - 17:03
- Tuesday, September 7, 2010 - 11:52
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
